Director/PDMR Shareholding

Smith & Nephew Plc

21 July 2023

 

SMITH & NEPHEW PLC

21 July 2023

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

On 20 July 2023, Smith & Nephew plc (the "Company") received notification of the following transactions as detailed below.

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc SPON ADR American Depositary Shares (ADS)
Identification code	ISIN: US83175M2052
Nature of the transaction	Purchase of American Depository Shares as participants of the Company's Employee Stock Purchase Plan.
Date of Transaction	2023 - 07 - 11
Place of Transaction	New York Stock Exchange

Name	Director / PDMR	Price ($)	Volume	Aggregated information
Bradley Cannon (President Sports Medicine & ENT)	PDMR	23.20	457.97414	N/A Single Transaction
Mizanu Kebede (Chief Quality and Regulatory Affairs Officer)	PDMR	23.20	94.26164	N/A Single Transaction
Deepak Nath (Chief Executive Officer)	Director	23.20	457.97414	N/A Single Transaction
Paul Connolly (President Global Operations)	PDMR	23.20	457.97414	N/A Single Transaction
Scott Schaffner (President Sports Medicine)	PDMR	23.20	219.48017	N/A Single Transaction

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Sarah Carne  

Deputy Company Secretary

Smith & Nephew plc

Tel:  [phone]

 

END